跳至主要内容
临床试验/ACTRN12621000688886
ACTRN12621000688886尚未招募4 期

A double-blinded randomised control trial evaluating the efficacy of additional long-term low-dose Clarithromycin versus standard of care on post-operative symptomatic outcomes in the treatment of non-eosinophilic Chronic Rhinosinusitis in adults

Professor Alkis Psaltis0 个研究点目标入组 50 人开始时间: 2021年6月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants who meet ALL the following criteria will be offered inclusion in the study:
  • Those who have had symptoms of chronic rhinosinusitis that has been previously persistent for greater than 3 months
  • Are over 18 years of age
  • Are English speaking
  • Can give written informed consent
  • Have underwent endoscopic sinus surgery prior
  • Have a phenotype of non-eCRS on histological assessment
  • Disease control has not been established 6 weeks post-op
  • Can commit to return to the clinic for 12- and 18-weeks postoperative endoscopic examination.

排除标准

  • Participants who meet one the following criteria will be excluded from the study:
  • Allergy to macrolides
  • language other than English spoken
  • Pregnant or breastfeeding
  • History of cardiac disease
  • Allergy to steroids
  • Covid-19 positive

研究者

发起方
Professor Alkis Psaltis

相似试验